{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:24:02Z","timestamp":1787775842363,"version":"build-2784847793"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 1","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:p>An innovative method in oncology, cancer immunotherapy uses the body\u2019s immune system to fight cancer cells. Despite its potential, nonspecific inflammation and autoimmunity provide major obstacles to the clinical implementation of immunotherapy. The goal of recent developments in medication delivery technology was to improve these treatments\u2019 effectiveness and safety. This systematic review explores innovative approaches such as nanoparticle-based delivery systems, biomaterial scaffolds, injectable hydrogels, transdermal delivery methods, and T-cell therapy delivery technologies. Nanoparticles are shown to improve drug localization and modulate pharmacokinetics, while biomaterials provide platforms for controlled and localized release of immunotherapies, reducing systemic toxicity. Injectable scaffolds create local immunogenic environments without requiring surgical implantation and transdermal delivery systems like microneedle patches enhance local immune activation. Advances in T-cell therapy delivery, such as DNA nanocarriers for in situ engineering and surface-conjugated nanoparticles, are intended to enhance the localization and effectiveness of adoptive T-cell therapies. Taken as a whole, these developments provide potential answers to the present problems with cancer immunotherapy, opening the door to safer and more efficient forms of treatment. Further research is essential to optimize these technologies for clinical application, ensuring long-term safety and efficacy.<\/jats:p>","DOI":"10.4103\/jpbs.jpbs_1375_24","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T10:06:47Z","timestamp":1740737207000},"page":"S70-S73","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Innovations in Cancer Immunotherapy Drug Delivery Technologies: A Systematic Review"],"prefix":"10.4103","volume":"17","author":[{"given":"Kavita","family":"Sharma","sequence":"first","affiliation":[{"name":"Consultant Oral and Maxillofacial Surgeon, Bhopal, Madhya Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhuri","family":"Shah","sequence":"additional","affiliation":[{"name":"Consultant Oral and Maxillofacial Surgeon, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samiksha","family":"Gour","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Dayananda Sagar College of Dental Sciences, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rituparna","family":"Mitra","sequence":"additional","affiliation":[{"name":"Consultant Oral and Maxillofacial Surgeon, Bhopal, Madhya Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidhhi","family":"Bihani","sequence":"additional","affiliation":[{"name":"Department of Oral and Maxillofacial Surgery, Bharati Vidyapeeth Dental College and Hospital, Sangli, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehal","family":"Chandgothia","sequence":"additional","affiliation":[{"name":"Consultant Oral and Maxillofacial Surgeon, Navi Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"R1-20250513","doi-asserted-by":"crossref","first-page":"14467","DOI":"10.1073\/pnas.1508516112","article-title":"Engineering opportunities in cancer immunotherapy","volume":"112","author":"Jeanbart","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R2-20250513","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1073\/pnas.1316312111","article-title":"TRAIL-coated leukocytes that kill cancer cells in the circulation","volume":"111","author":"Mitchell","year":"2014","journal-title":"Proc Natl Acad Sci"},{"key":"R3-20250513","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines\u2014A new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"R4-20250513","doi-asserted-by":"crossref","first-page":"e1632","DOI":"10.1002\/wnan.1632","article-title":"Advances in engineering local drug delivery systems for cancer immunotherapy","volume":"12","author":"Abdou","year":"2020","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"R5-20250513","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"R6-20250513","first-page":"8ra19","article-title":"In situ regulation of dendritic cells and T cells mediates tumor regression in mice","volume":"2","author":"Ali","year":"2010","journal-title":"Sci Transl Med"},{"key":"R7-20250513","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/nbt.3071","article-title":"Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy","volume":"33","author":"Kim","year":"2015","journal-title":"Nature Biotechnol"},{"key":"R8-20250513","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1021\/acs.nanolett.5b05030","article-title":"Enhanced cancer immunotherapy by microneedle patch-assisted delivery of anti-PD1 antibody","volume":"16","author":"Wang","year":"2016","journal-title":"Nano Lett"},{"key":"R9-20250513","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nm.2198","article-title":"Therapeutic cell engineering with surface-conjugated synthetic nanoparticles","volume":"16","author":"Stephan","year":"2010","journal-title":"Nat Med"},{"key":"R10-20250513","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nnano.2017.57","article-title":"In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers","volume":"12","author":"Smith","year":"2017","journal-title":"Nat Nanotechnol"},{"key":"R11-20250513","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nbt.3104","article-title":"Biopolymer implants enhance the efficacy of adoptive T-cell therapy","volume":"33","author":"Stephan","year":"2014","journal-title":"Nat Biotechnol"},{"key":"R12-20250513","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1002\/smll.201402369","article-title":"Biodegradable nanoellipsoidal artificial antigen presenting cells for antigen specific T-cell activation","volume":"11","author":"Meyer","year":"2015","journal-title":"Small"}],"container-title":["Journal of Pharmacy and Bioallied Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jpbs.jpbs_1375_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:43:37Z","timestamp":1787773417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jpbs.jpbs_1375_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":12,"journal-issue":{"issue":"Suppl 1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jpbs.jpbs_1375_24","relation":{},"ISSN":["0976-4879","0975-7406"],"issn-type":[{"value":"0976-4879","type":"print"},{"value":"0975-7406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"2024-09-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}